Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Risk Analysis from the Burden of Lyme Disease (BOLD) Study
Pfizer Ltd, Tadworth KT20 7NS, Surrey, England.
Pfizer Corp Austria GmbH, A-1210 Vienna, Austria..
Medical University of Bialystok, Poland.
University Medical Centre Ljubljana, Slovenia.
Show others and affiliations
2026 (English)In: Pathogens, E-ISSN 2076-0817, Vol. 15, no 9, article id 961Article in journal (Refereed) Published
Abstract [en]

Lyme borreliosis (LB) is endemic in many European countries. The prospective, epidemiological Burden of Lyme Disease (BOLD) study used unified case definitions to characterise LB burden in Europe. A retrospective case-control study was nested within the BOLD study to better understand LB risk factors. LB patients were evaluated at 14 healthcare practices in high-LB-incidence areas in six European countries: the Czech Republic, Germany, Poland, Slovakia, Slovenia, and Sweden between April 2021 and December 2022. Enrolled cases and age-group-matched controls were interviewed about potential risk factors, and multivariate regression analysis was used to analyse the responses. Patients with LB were more likely than matched controls to live in neighbourhoods with >50% woods, to have a garden that is composed of less than half dense trees, and to have a garden visited by wild animals. Characteristics associated with lower LB risk included being male and not having a bird feeder. The results are suggestive of risk associated with edge-of-the-forest areas, aligning with the previous literature on the increased risk of LB with forest fragmentation. Our findings support the importance of landscape structure and human-environment interactions in shaping LB risk.

Place, publisher, year, edition, pages
MDPI, 2026. Vol. 15, no 9, article id 961
Keywords [en]
Lyme borreliosis, Lyme disease, risk factors, Europe, burden of disease
National Category
Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:bth-30609DOI: 10.3390/pathogens15090961ISI: 001892883000001PubMedID: 42796729Scopus ID: 2-s2.0-105052930431OAI: oai:DiVA.org:bth-30609DiVA, id: diva2:2111543
Funder
Pfizer ABAvailable from: 2026-10-20 Created: 2026-10-20 Last updated: 2026-10-23Bibliographically approved

Open Access in DiVA

fulltext(2376 kB)26 downloads
File information
File name FULLTEXT01.pdfFile size 2376 kBChecksum SHA-512
68060f044b725fd9ef9beaa4dd8a0889a6d6512d87eaac938336366ae0bdc7c7f7bd7a02941ed14af146343cf9d228c2036d8f507f36b1a41270f0928ba726bd
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Sanmartin Berglund, Johan

Search in DiVA

By author/editor
Sanmartin Berglund, Johan
By organisation
Department of Health
In the same journal
Pathogens
Public Health, Global Health and Social Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 26 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 65253 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf